Company intelligence / Profile preview

Qivana

Ownership: Private
Employees: ~40
Development stage: Commercial

Overview

Qivana was a direct sales company founded in 2008 that marketed natural health products—primarily probiotics and nutritional supplements—licensed from universities and scientists. Its flagship products included the Qore Probiotic system for digestive health and Metaboliq for weight management. The company operated via multi-level marketing with international expansion plans around 2010–2014. There is no evidence of clinical trials or drug development pipeline.

Therapeutic areas: GastroenterologyEndocrinologyOther
Modalities: ProbioticNutritional supplementHerbal product
Industry: Food & Nutrition

Drug pipeline

1 asset

Qore

Commercial

Indications: Digestive health, Immune system health, Inflammation

Partnerships

Academic licensors

Beyond the preview

Go deeper on Qivana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qivana.

Explore the full profile